WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.–(HSMN NewsFeed)–Merck & Co., Inc., Schering-Plough Corporation and the companies’ cholesterol joint venture, Merck/Schering-Plough Pharmaceuticals (MSP), today announced that they have entered into agreements t…
Biopharmaceuticals, Cardiology, Litigation
Merck, Schering-Plough, VYTORIN, ezetimibe, simvastatin, ZETIA, ezetimibe

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Merck and Schering-Plough Resolve Previously Disclosed Civil Class Action Lawsuits Related to VYTORIN(R) (ezetimibe/simvastatin) and ZETIA(R) (ezetimibe)”
Leave a Comment